January 24, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused ...
The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...
Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion centers.
The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological barriers which protect cells.
The U.S. Government Accountability Office (GAO) publicly released a report entitled “New Chemicals Program: EPA Needs a ...
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...
The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...
It’s not only Washington, D.C., where “efficiency” has become the buzzword du jour. With California facing an uncertain fiscal future, Gov. Gavin Newsom ...
Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past year. Though the stock soared at the onset of 2024, ...
The Democratic governor addressed the issues plaguing her party. Will it be enough to rescue her electoral brand?
The Democratic governor addressed the issues plaguing her party. Will it be enough to rescue her electoral brand?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback